Detalles de la búsqueda
1.
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Blood
; 143(14): 1391-1398, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38153913
2.
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.
Blood
; 131(13): 1464-1475, 2018 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29348129
3.
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
Acta Haematol
; 143(3): 217-231, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31590170
4.
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy.
Blood
; 130(18): 2027-2031, 2017 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28827408
5.
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
Blood
; 128(6): 774-82, 2016 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121472
6.
Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
Int J Cancer
; 139(8): 1799-809, 2016 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27253354
7.
Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.
Biol Blood Marrow Transplant
; 20(10): 1522-9, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24907626
8.
A Multicentre, Randomized Trial in Adults with de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib versus Imatinib in Combination with Low-Intensity Chemotherapy, to Compare End of Therapy with Indication for Stem Cell Transplantation versus Tyrosine Kinase Inhibitor, Blinatumomab, and Chemotherapy in Optimal Responders, and to Evaluate Blinatumomab in Suboptimal Responders (GMALL-EVOLVE).
Oncol Res Treat
; : 1-4, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754400
9.
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
J Clin Oncol
; 42(3): 273-282, 2024 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37883727
10.
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
Leukemia
; 38(6): 1315-1322, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744919
11.
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia.
BMC Pharmacol Toxicol
; 21(1): 70, 2020 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32993794
12.
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.
Bone Marrow Transplant
; 55(7): 1410-1420, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32001801
13.
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia.
Leukemia
; 34(8): 2087-2101, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32439895
14.
First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults.
Curr Opin Oncol
; 21 Suppl 1: S43-6, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19561414
15.
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
Cell Rep
; 27(7): 2022-2028.e3, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31091442
16.
An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.
Haematologica
; 92(7): 970-3, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17606448
17.
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
Cancer Res
; 65(7): 2537-41, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15805245
18.
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.
Am J Case Rep
; 18: 1099-1109, 2017 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29033451
19.
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
Cancer Cell
; 30(6): 849-862, 2016 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27916615
20.
Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
Eur J Haematol
; 85(5): 457-9, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20659156